Kringle Pharma

Kringle Pharma Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $15.6M
Latest Deal Amount
  • Investors
  • 16

Kringle Pharma General Information

Description

Manufacturer of pharmaceutical products intended to be used for the treatment of cancer and incurable diseases. The company's pharmaceutical products include HGF medicines derived from the innovative research and development of HGF (for incurable diseases) and NK4 (for tumors), enables pharmaceutical researchers to develop medicines to overcome acute spinal cord injury and amyotrophic lateral sclerosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 207 Saito Bio-Incubator
  • 7-7-15 Saitoasagi, Ibaraki
  • Osaka, 567-0085
  • Japan
+81 000-000-0000

Kringle Pharma Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kringle Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 08-Apr-2020 $15.6M 000.00 Completed Clinical Trials - Phase 1
3. Later Stage VC 05-Dec-2016 00.000 000.00 Completed Clinical Trials - Phase 1
2. Grant 02-Apr-2008 $15.7M Completed Clinical Trials - Phase 1
1. Later Stage VC 10-Jan-2008 $15.7M $15.7M Completed Clinical Trials - Phase 1

Kringle Pharma Executive Team (4)

Name Title Board Seat Contact Info
Kunio Iwatani Chairman, Co-Chief Executive Officer & President
Kiichi Adachi Ph.D President, Co-Chief Executive Officer & Board Member
Kunio Matsumoto Co-Founder

1 Former Executive

Kringle Pharma Board Members (7)

To view Kringle Pharma‘s full board member team, request access »
Name Representing Role Since
Akihiro Tomoyasu Ph.D Self Board Member 000 0000
Etsuro Hashimura Kringle Pharma Board Member 000 0000
Hiroshi Ishiai Ph.D Kringle Pharma Board Member 000 0000
Hisashi Mitsuguchi DBJ Capital Board Member 000 0000
Kohichiro Yoshino Ph.D Kringle Pharma Board Member 000 0000

Kringle Pharma Investors (16)

To view Kringle Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CEJ Capital Venture Capital Minority 000 0000 000000 0
Chishima Real Estate Corporation Minority 000 0000 000000 0
Osaka University Venture Capital Venture Capital Minority 000 0000 000000 0
Toho Holdings Co. Corporation Minority 000 0000 000000 0
Cyberdyne (Therapeutic Devices) Corporation Minority 000 0000 000000 0

Ready to get started?

Request a free trial